NanoCellect Biomedical
Biotechnology company developing innovative microfluidic-based solutions to sort viable cells for antibody discovery, cell line development, single-cell omics, and plant and animal genomics research.
Notes
NanoCellect Biomedical develops innovative microfluidic-based cell sorting solutions that enable researchers to sort viable cells for a wide range of applications. The company's WOLF and CYTO cell sorting systems use gentle microfluidic technology that maintains cell viability better than traditional fluorescence-activated cell sorting (FACS) approaches.
NanoCellect's platforms are used in antibody discovery, cell line development, single-cell omics, and plant and animal genomics research, enabling scientists to isolate specific cell populations while preserving cell health and function.
Team
- Information on leadership team pending further research
Additional Research Findings
- Founded in 2009
- Headquarters in San Diego, California
- WOLF and CYTO cell sorting platforms
- Microfluidic technology for gentle cell sorting
- Applications in single-cell genomics
- Used for antibody discovery workflows
- Cell line development applications
- Part of San Diego biotech cluster
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Illumina Ventures | San Francisco, California, USA | biotech-focused | seedseries-a+1 | 32 |